EFM
VNDA icon

E Fund Management’s Vanda Pharmaceuticals VNDA Stock Holding History

E Fund Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$80.2K Buy
+11,603
New +$89.5K ﹤0.01% 478
2023
Q3 		– Sell
-11,832
Closed -$78K – 322
2023
Q2 		$78K Sell
11,832
-1,228
-9% -$7.87K 0.01% 304
2023
Q1 		$89K Buy
+13,060
New +$91.8K 0.01% 324

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

E Fund Management's VNDA Position: Q1 2026 in Review

E Fund Management opened a new position in Vanda Pharmaceuticals (VNDA) in Q1 2026: 11,603 shares worth $80.2K. The stake represents ﹤0.01% of the portfolio and ranks #478 among its holdings. This is a return to the name: E Fund Management previously reported a position in VNDA as recently as Q2 2023.

E Fund Management first reported a position in VNDA in Q1 2023 and has held it in 3 quarters since. The position peaked at $89K in Q1 2023. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • E Fund Management held 11,603 shares of Vanda Pharmaceuticals worth $80.2K as of Q1 2026.
  • Vanda Pharmaceuticals was a new E Fund Management position in Q1 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of E Fund Management's portfolio in Q1 2026, its #478 holding.
  • E Fund Management first reported a position in Vanda Pharmaceuticals in Q1 2023 and has held it in 3 quarters since.
  • E Fund Management's Vanda Pharmaceuticals position peaked at $89K in Q1 2023.
  • 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on E Fund Management's 13F filing for Q1 2026, filed 13 Apr 2026.